Home › Companies › FULCRUM THERAPEUTICS INC. › 2024-2025

FULCRUM THERAPEUTICS INC. 2024-2025 Proxy Voting Records

Compiled from SEC Form N-PX filings and FULCRUM THERAPEUTICS INC.’s Form 8-K, filed 2025-06-27 (Item 5.07 on EDGAR). Page generated 02 October 2026.

9Reported items
125Asset managers
951Fund votes
2025-06-26Meeting date

Proxy season: 2024-2025 2025-2026

Explore FULCRUM THERAPEUTICS INC. in the interactive database Compare manager voting policies

Official 2024-2025 meeting results reported by FULCRUM THERAPEUTICS INC.

These tallies are FULCRUM THERAPEUTICS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2025-06-27 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

FULCRUM THERAPEUTICS INC. — official shareholder meeting results, meeting held 2025-06-26
Ballot item	For	Against	Abstain	Withheld	Broker non-votes	Outcome
Elect Director: Katina Dorton	44,618,582	--	--	1,601,489	3,317,555	Majority: yes
Elect Director: Robert J. Gould	43,847,378	--	--	2,372,693	3,317,555	Majority: yes
Elect Director: Kate Haviland	33,203,495	--	--	13,016,576	3,317,555	Majority: yes
Fulcrum's stockholders approved, on a non-binding advisory basis, the compensation of Fulcrum's named executive officers.	46,099,800	111,967	8,304	--	3,317,555	Majority: yes
Fulcrum's stockholders selected "one" year as the non-binding recommended frequency for future non-binding advisory votes on the compensation of Fulcrum's named executive officers.	49,513,190	22,808	1,628	--	0	Majority: yes

Source: FULCRUM THERAPEUTICS INC., Form 8-K, filed with the SEC on 2025-06-27 — read the filing on EDGAR.

How asset managers voted at the FULCRUM THERAPEUTICS INC. 2024-2025 meeting

Each item below shows how the 125 asset managers that disclosed a FULCRUM THERAPEUTICS INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of FULCRUM THERAPEUTICS INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. A non-binding advisory vote on the frequency of future executive compensation advisory votes; and

SECTION 14A SAY-ON-PAY VOTESMajority of the votes cast: yes

Combines 7 wordings of this item as funds reported it.

99.9% Majority: yes · of votes cast

FOR 99.9%

FOR: 49,513,190AGAINST: 22,808

FULCRUM THERAPEUTICS INC.’s own tally for this item (“Fulcrum's stockholders selected "one" year as the non-binding recommended frequency for future non-binding advisory votes on the compensation of Fulcrum's named executive officers.”): 49,513,190 for, 22,808 against, per its Form 8-K filed 2025-06-27 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 53,979,306 outstanding shares: 92% for, 0.1% against (92% of the company cast a for/against vote).

The 119 asset managers below cast 99.9% of the shares they voted on this item FOR (5,357,428 for, 386 against).

FOR 14%ONE YEAR 71%14%

FOR: 5,357,428 (14.1%)AGAINST: 386 (0.0%)ONE YEAR: 27,195,374 (71.4%)1 YEAR: 5,287,507 (13.9%)THREE YEARS: 208,936 (0.5%)3 YEARS: 14,631 (0.0%)

Largest asset managers voting on “A non-binding advisory vote on the frequency of future executive compensation advisory votes; and” at FULCRUM THERAPEUTICS INC., 2024-2025
Asset manager	For	Vote
RA CAPITAL MANAGEMENT, L.P.	0	One Year
TCG Crossover Management, LLC	5,250,000	For
SUVRETTA CAPITAL MANAGEMENT, LLC	0	One Year
BlackRock	0	1 Year
Vanguard	0	One Year
GEODE CAPITAL MANAGEMENT, LLC	0	One Year
Fidelity	0	One Year
Woodline Partners LP	0	One Year
State Street	0	One Year
Charles Schwab	0	1 Year
BESSEMER TRUST Co NATIONAL ASSOCIATION	0	One Year
Aberdeen	0	One Year
ADAR1 Capital Management, LLC	0	One Year
DE Shaw	0	One Year
Northern Trust	0	1 Year
Bessemer Trust CO of Delaware, N.A.	0	One Year
BESSEMER TRUST CO	0	One Year
BESSEMER TRUST Co OF FLORIDA	0	One Year
Bessemer Trust Co of Nevada, National Association	0	One Year
American Century	0	One Year
Citadel	0	One Year
Dimensional	0	Three Years
Equitable	0	One Year
Nuveen	0	One Year
TIAA	0	One Year

Showing the 25 largest of 119 asset managers. See all 119 in the interactive database.

2. A non-binding advisory vote on executive compensation;

SECTION 14A SAY-ON-PAY VOTES

Combines 3 wordings of this item as funds reported it.

99.9% fund support · no official result

FOR 99.9%

The 118 asset managers below cast 99.9% of the shares they voted on this item FOR (37,634,144 for, 19,083 against).

FOR: 37,634,144 (99.9%)AGAINST: 19,083 (0.1%)

Largest asset managers voting on “A non-binding advisory vote on executive compensation;” at FULCRUM THERAPEUTICS INC., 2024-2025
Asset manager	For	Vote
RA CAPITAL MANAGEMENT, L.P.	9,332,719	For
SUVRETTA CAPITAL MANAGEMENT, LLC	5,223,879	For
Nantahala Capital Management, LLC	4,306,473	For
BlackRock	3,536,707	For
Vanguard	3,328,954	For
GEODE CAPITAL MANAGEMENT, LLC	1,217,603	For
Fidelity	1,131,350	For
Woodline Partners LP	897,617	For
State Street	882,115	For
Charles Schwab	767,902	For
Exome Asset Management LLC	622,887	For
BESSEMER TRUST Co NATIONAL ASSOCIATION	574,951	For
Aberdeen	456,640	For
ADAR1 Capital Management, LLC	447,673	For
DE Shaw	355,193	For
Northern Trust	294,124	For
Bessemer Trust CO of Delaware, N.A.	292,760	For
BESSEMER TRUST CO	289,237	For
BESSEMER TRUST Co OF FLORIDA	289,237	For
Bessemer Trust Co of Nevada, National Association	289,237	For
American Century	249,804	For
Citadel	223,623	For
Dimensional	187,464	For
Equitable	168,411	For
Nuveen	152,992	For

Showing the 25 largest of 118 asset managers. See all 118 in the interactive database.

3. Election Class III Directors, nominated by our Board of Directors, each to serve for a three-year term expiring at the 2028 annual meeting of stockholders: Kate Haviland

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 2 wordings of this item as funds reported it.

72% Majority: yes · of votes cast

FOR 72%WITHHELD 28%

FOR: 33,203,495WITHHELD: 13,016,576

FULCRUM THERAPEUTICS INC.’s own tally for this item (“Elect Director: Kate Haviland”): 33,203,495 for, 13,016,576 withheld, per its Form 8-K filed 2025-06-27 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 53,979,306 outstanding shares: 62% for, 24% withheld (86% of the company cast a for/withheld vote).

The 42 asset managers below cast 100% of the shares they voted on this item FOR (1,436,899 for, 0 against).

FOR 18%ABSTAIN 82%

FOR: 1,436,899 (18.3%)ABSTAIN: 6,420,594 (81.7%)

Largest asset managers voting on “Election Class III Directors, nominated by our Board of Directors, each to serve for a three-year term expirin” at FULCRUM THERAPEUTICS INC., 2024-2025
Asset manager	For	Abstain	Vote
Vanguard	0	3,265,334	Abstain
BlackRock	173,098	1,634,588	Abstain
Fidelity	1,082,655	45,000	For
Charles Schwab	0	383,951	Abstain
Aberdeen	0	228,320	Abstain
Equitable	0	168,411	Abstain
TIAA	152,992	0	For
American Century	0	124,902	Abstain
QUANTITATIVE MASTER SERIES LLC	0	108,026	Abstain
Goldman Sachs	0	65,323	Abstain
Lincoln Financial	0	48,242	Abstain
Invesco	0	45,343	Abstain
Northern Trust	0	40,161	Abstain
Global X	0	31,932	Abstain
AIG/SunAmerica	0	28,209	Abstain
Pacific Life	0	23,865	Abstain
John Hancock	0	22,562	Abstain
Bridge Builder Trust	0	21,498	Abstain
MASTER INVESTMENT PORTFOLIO	19,002	0	For
Voya	0	18,548	Abstain
PACE SELECT ADVISORS TRUST	0	16,282	Abstain
Jackson National	0	14,631	Abstain
Prudential/PGIM	0	11,430	Abstain
ProShares	0	10,775	Abstain
AQR	0	10,274	Abstain

Showing the 25 largest of 42 asset managers. See all 42 in the interactive database.

4. Election Class III Directors, nominated by our Board of Directors, each to serve for a three-year term expiring at the 2028 annual meeting of stockholders: Katina Dorton

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 3 wordings of this item as funds reported it.

97% Majority: yes · of votes cast

FOR 97%

FOR: 44,618,582WITHHELD: 1,601,489

FULCRUM THERAPEUTICS INC.’s own tally for this item (“Elect Director: Katina Dorton”): 44,618,582 for, 1,601,489 withheld, per its Form 8-K filed 2025-06-27 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 53,979,306 outstanding shares: 83% for, 3% withheld (86% of the company cast a for/withheld vote).

The 42 asset managers below cast 100% of the shares they voted on this item FOR (7,750,334 for, 0 against).

FOR 99%

FOR: 7,750,334 (98.6%)ABSTAIN: 107,159 (1.4%)

Largest asset managers voting on “Election Class III Directors, nominated by our Board of Directors, each to serve for a three-year term expirin” at FULCRUM THERAPEUTICS INC., 2024-2025
Asset manager	For	Abstain	Vote
Vanguard	3,265,334	0	For
BlackRock	1,807,686	0	For
Fidelity	1,127,655	0	For
Charles Schwab	383,951	0	For
Aberdeen	228,320	0	For
Equitable	98,521	69,890	For
TIAA	152,992	0	For
American Century	124,902	0	For
QUANTITATIVE MASTER SERIES LLC	108,026	0	For
Goldman Sachs	65,323	0	For
Lincoln Financial	38,200	10,042	For
Invesco	45,343	0	For
Northern Trust	40,161	0	For
Global X	31,932	0	For
AIG/SunAmerica	28,209	0	For
Pacific Life	23,865	0	For
John Hancock	22,562	0	For
Bridge Builder Trust	21,498	0	For
MASTER INVESTMENT PORTFOLIO	19,002	0	For
Voya	18,548	0	For
PACE SELECT ADVISORS TRUST	16,282	0	For
Jackson National	0	14,631	Abstain
Prudential/PGIM	0	11,430	Abstain
ProShares	10,775	0	For
AQR	10,274	0	For

Showing the 25 largest of 42 asset managers. See all 42 in the interactive database.

5. Election Class III Directors, nominated by our Board of Directors, each to serve for a three-year term expiring at the 2028 annual meeting of stockholders: Robert J. Gould

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 3 wordings of this item as funds reported it.

95% Majority: yes · of votes cast

FOR 95%

FOR: 43,847,378WITHHELD: 2,372,693

FULCRUM THERAPEUTICS INC.’s own tally for this item (“Elect Director: Robert J. Gould”): 43,847,378 for, 2,372,693 withheld, per its Form 8-K filed 2025-06-27 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 53,979,306 outstanding shares: 81% for, 4% withheld (86% of the company cast a for/withheld vote).

The 42 asset managers below cast 100% of the shares they voted on this item FOR (7,706,625 for, 0 against).

FOR 98%

FOR: 7,706,625 (98.1%)ABSTAIN: 150,868 (1.9%)

Largest asset managers voting on “Election Class III Directors, nominated by our Board of Directors, each to serve for a three-year term expirin” at FULCRUM THERAPEUTICS INC., 2024-2025
Asset manager	For	Abstain	Vote
Vanguard	3,265,334	0	For
BlackRock	1,807,686	0	For
Fidelity	1,127,655	0	For
Charles Schwab	383,951	0	For
Aberdeen	228,320	0	For
Equitable	98,521	69,890	For
TIAA	152,992	0	For
American Century	124,902	0	For
QUANTITATIVE MASTER SERIES LLC	108,026	0	For
Goldman Sachs	65,323	0	For
Lincoln Financial	0	48,242	Abstain
Invesco	45,343	0	For
Northern Trust	40,161	0	For
Global X	31,932	0	For
AIG/SunAmerica	28,209	0	For
Pacific Life	23,865	0	For
John Hancock	22,562	0	For
Bridge Builder Trust	21,498	0	For
MASTER INVESTMENT PORTFOLIO	19,002	0	For
Voya	18,548	0	For
PACE SELECT ADVISORS TRUST	16,282	0	For
Jackson National	0	14,631	Abstain
Prudential/PGIM	0	11,430	Abstain
ProShares	10,775	0	For
AQR	10,274	0	For

Showing the 25 largest of 42 asset managers. See all 42 in the interactive database.

6. RATIFICATION OF THE APPOINTMENT OF ERNST & YOUNG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2025.

AUDIT-RELATED

99.9% fund support · no official result

FOR 99.9%

The 42 asset managers below cast 99.9% of the shares they voted on this item FOR (7,856,327 for, 1,166 against).

FOR: 7,856,327 (100.0%)AGAINST: 1,166 (0.0%)

Largest asset managers voting on “RATIFICATION OF THE APPOINTMENT OF ERNST & YOUNG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR ” at FULCRUM THERAPEUTICS INC., 2024-2025
Asset manager	For	Vote
Vanguard	3,265,334	For
BlackRock	1,807,686	For
Fidelity	1,127,655	For
Charles Schwab	383,951	For
Aberdeen	228,320	For
Equitable	168,411	For
TIAA	152,992	For
American Century	124,902	For
QUANTITATIVE MASTER SERIES LLC	108,026	For
Goldman Sachs	65,323	For
Lincoln Financial	48,242	For
Invesco	45,343	For
Northern Trust	40,161	For
Global X	31,932	For
AIG/SunAmerica	28,209	For
Pacific Life	23,865	For
John Hancock	22,562	For
Bridge Builder Trust	21,498	For
MASTER INVESTMENT PORTFOLIO	19,002	For
Voya	18,548	For
PACE SELECT ADVISORS TRUST	16,282	For
Jackson National	14,631	For
Prudential/PGIM	11,430	For
ProShares	10,775	For
AQR	10,274	For

Showing the 25 largest of 42 asset managers. See all 42 in the interactive database.

7. Advisory Vote to Ratify Named Executive Officers' Compensation

SECTION 14A SAY-ON-PAY VOTES

100% fund support · no official result

FOR 100%

The 3 asset managers below cast 100% of the shares they voted on this item FOR (2,425,168 for, 0 against).

FOR: 2,425,168 (100.0%)

Largest asset managers voting on “Advisory Vote to Ratify Named Executive Officers' Compensation” at FULCRUM THERAPEUTICS INC., 2024-2025
Asset manager	For	Vote
ADAGE CAPITAL PARTNERS GP, L.L.C.	2,376,528	For
JPMorgan	24,370	For
ALGERT GLOBAL LLC	24,270	For

8. A non-binding advisory vote to approve the compensation of our named executive officers

SECTION 14A SAY-ON-PAY VOTESMajority of the votes cast: yes

Combines 2 wordings of this item as funds reported it.

99.7% Majority: yes · of votes cast

FOR 99.7%

FOR: 46,099,800AGAINST: 111,967

FULCRUM THERAPEUTICS INC.’s own tally for this item (“Fulcrum's stockholders approved, on a non-binding advisory basis, the compensation of Fulcrum's named executive officers.”): 46,099,800 for, 111,967 against, per its Form 8-K filed 2025-06-27 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 53,979,306 outstanding shares: 85% for, 0.3% against (86% of the company cast a for/against vote).

The 2 asset managers below cast 100% of the shares they voted on this item FOR (5,438,304 for, 0 against).

FOR 100%

FOR: 5,438,304 (100.0%)

Largest asset managers voting on “A non-binding advisory vote to approve the compensation of our named executive officers” at FULCRUM THERAPEUTICS INC., 2024-2025
Asset manager	For	Against	Abstain	Withheld	Vote
TCG Crossover Management, LLC	5,250,000	0	0	0	For
Catalio Capital Management, LP	188,304	0	0	0	For

9. Advisory Vote on Say on Pay Frequency

SECTION 14A SAY-ON-PAY VOTESMajority of the votes cast: yes

99.9% Majority: yes · of votes cast

FOR 99.9%

FOR: 49,513,190AGAINST: 22,808

No shares were cast for or against this item by the managers below — every disclosed position was an abstention or was not voted.

1-YEAR 99%

1-YEAR: 2,376,528 (99.0%)ONE YEAR: 24,370 (1.0%)

Largest asset managers voting on “Advisory Vote on Say on Pay Frequency” at FULCRUM THERAPEUTICS INC., 2024-2025
Asset manager	For	Against	Abstain	Withheld	Vote
ADAGE CAPITAL PARTNERS GP, L.L.C.	0	0	0	0	1-Year
JPMorgan	0	0	0	0	One Year

Largest FULCRUM THERAPEUTICS INC. shareholders voting in 2024-2025

Ranked by the number of FULCRUM THERAPEUTICS INC. shares each manager voted on the most widely held ballot item of the 2024-2025 meeting, shown as a share of the 53,979,306 shares outstanding at the time of that meeting.

Top FULCRUM THERAPEUTICS INC. shareholders by shares voted, 2024-2025
#	Asset manager	% of shares outstanding
1	RA CAPITAL MANAGEMENT, L.P.	17.29%
2	TCG Crossover Management, LLC	9.73%
3	SUVRETTA CAPITAL MANAGEMENT, LLC	9.68%
4	BlackRock	6.55%
5	Vanguard	6.17%
6	GEODE CAPITAL MANAGEMENT, LLC	2.26%
7	Fidelity	2.10%
8	Woodline Partners LP	1.66%
9	State Street	1.63%
10	Charles Schwab	1.42%

Reported FULCRUM THERAPEUTICS INC. ownership

Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).

FULCRUM THERAPEUTICS INC. beneficial owners on record for the 2024-2025 proxy season
Holder	% outstanding	Disclosure
RA Capital Management, L.P.	18.95%	DEF14A
TCG Crossover GP II, LLC	9.73%	13G
BlackRock	8.73%	13F
Suvretta Capital Management, LLC	6.31%	DEF14A
Vanguard Group	5.97%	13F
Nantahala Capital Management, LLC	5.65%	13G
Adage Capital Partners GP, LLC.	5.56%	DEF14A
Adage Capital Management, L.P.	4.51%	13G
Dimensional Fund Advisors	2.61%	13F
Alex C. Sapir	2.40%	DEF14A

Percentages above are of 53,979,306 shares outstanding, as reported by FULCRUM THERAPEUTICS INC. on its Form 10-Q dated 2025-04-24 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from FULCRUM THERAPEUTICS INC.’s 10-Q dated 2025-04-24. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.

At FULCRUM THERAPEUTICS INC.'s shareholder meeting held 2025-06-26, in the 2024-2025 proxy season, 125 asset managers reported how they voted in their SEC Form N-PX filings, covering 951 separate fund positions. Their filings are grouped here into 9 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — A non-binding advisory vote on the frequency of future executive compensation advisory votes… — FOR was 99.9% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: FULCRUM THERAPEUTICS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2025-06-27.

FULCRUM THERAPEUTICS INC. proxy season coverage: 2024-2025 (this page) · 2025-2026.